Engine Biosciences
PrivateLast Round
Series A
Extension
Oct 31, 2023
Est. Valuation
$82M
Total Funding Raised
$80M
Company Overview
Engine Biosciences operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A Extension round in October 2023.
Engine Biosciences is a biotechnology company that develops precision oncology medicines and biomarkers by integrating machine learning with high-throughput biology and combinatorial genetics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Engine Biosciences Comparables
Compare Engine Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Waypoint Bio | 88% | |
| Relation Therapeutics | 81% | |
| Nucleome Therapeutics | 80% |
For institutional investors. Book with your work email.
Engine Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 31, 2023 | ||||
| Series A | May 26, 2021 | ||||
| Seed | Jan 31, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Engine Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nest.Bio | Series A, Seed |
| SEEDS Capital | Series A Extension |
| Vectr Ventures | Series A |
| Camford Capital | Series A, Seed |
| Baidu Ventures | Series A, Seed |
| WI Harper Group | Series A, Seed |
| ClavystBio | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 137% MoM.
- Jun 9, 2026
Grew 16% QoQ, from 31 to 36 employees.
For institutional investors. Book with your work email.
Engine Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Engine Biosciences's valuation, stock price, and market status.
Is Engine Biosciences a public or private company?
Engine Biosciences is a private company.
What is the current stock price of Engine Biosciences?
Engine Biosciences is a private company, so its shares have no public market price. Caplight tracks Engine Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Engine Biosciences worth (valuation)?
Engine Biosciences's valuation is estimated at $82.0M based on funding round data.
Can I buy Engine Biosciences stock?
Engine Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Engine Biosciences's last funding round?
Engine Biosciences's most recent funding round was Series A Extension on October 31, 2023.
Who are the main investors in Engine Biosciences?
Key investors in Engine Biosciences include 6 Dimensions Capital, Polaris Partners, DHVC.
Will Engine Biosciences IPO soon?
No public IPO plans have been announced for Engine Biosciences.
How can I track Engine Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Engine Biosciences's shares on secondary markets.